July 2022 tender notification
Pharmac is pleased to provide the latest tender results.
Download the tender notification [PDF 66 KB]
Tender results
Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2021/22 Invitation to Tender, dated 1 November 2021.
Some of the pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. Pharmac will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:
- For new listings, by 4pm on 12 August 2022 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4pm on the 12th of the month prior to the date of subsidy change
Pharmac cannot list a product (and pharmacies cannot claim) without this information.
More information about this process and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link).
Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest).
Pharmac cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2021/22 Tender – Principal Supply Status applies until 30 June 2025
Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to Pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand (Supplier) |
Date of listing |
Principal Supply Status date |
Brand |
|---|---|---|---|---|---|---|---|
|
Domperidone |
Tab 10 mg; 100 tablet blister pack |
$2.85 |
$4.00 |
Domperidone Viatris (Viatris) |
1 February 2023 |
1 July 2023 |
Pharmacy Health |
|
Fluoxetine hydrochloride |
Cap 20 mg; 90 capsule blister pack |
$2.91 (per 84 capsules) |
$3.13 |
Arrow – Fluoxetine (Teva) |
1 January 2023 |
1 June 2023 |
Fluox |
|
Fluoxetine hydrochloride |
Tab dispersible 20 mg, scored; 28 tablet blister pack |
$1.84 |
$2.50 |
Fluox (pharmacode 2618575) (Viatris) |
1 September 2022 |
1 February 2023 |
Fluox (pharmacode 2077817) |
|
Pantoprazole |
Tab EC 20 mg; 90 tablet bottle |
$2.02 (per 100 tablets) |
$1.99 |
Panzop Relief (Viatris) |
1 February 2023 |
1 July 2023 |
Panzop Relief (pharmacode 2496216) |
|
Pantoprazole |
Tab EC 40 mg; 90 tablet bottle |
$2.85 (per 100 tablets) |
$2.74 |
Panzop Relief (Viatris) |
1 February 2023 |
1 July 2023 |
Panzop Relief (pharmacode 2496224) |
|
Posaconazole |
Tab modified-release 100 mg; 24 tablet blister pack |
$869.86 |
$206.00 |
Posaconazole Juno (Juno) |
1 November 2022 |
1 April 2023 |
Noxafil |
|
Sertraline |
Tab 50 mg; 30 tablet blister pack |
$0.92 |
$0.99 |
Setrona (Douglas) |
1 November 2022 |
1 April 2023 |
Setrona AU (Douglas) |
|
Sertraline |
Tab 100 mg; 30 tablet blister pack |
$1.61 |
$1.74 |
Setrona (Douglas) |
1 November 2022 |
1 April 2023 |
Setrona AU (Douglas) |
|
Water |
Inj 10 ml ampoule; 50 ampoule pack |
$7.19 |
$7.60 |
Multichem (Multichem) |
1 April 2023 |
1 September 2023 |
Pfizer |
Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.
2. Tenders awarded to Pharmaceuticals where no other brand is listed
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand |
DV |
Date of price change |
Principal Supply date |
|---|---|---|---|---|---|---|---|
|
Sertraline |
Tab 50 mg; 30 tablet blister pack |
$0.92 |
$0.99 |
Setrona (Douglas) |
5% |
1 November 2022 |
1 April 2023 |
|
Sertraline |
Tab 100 mg; 30 tablet blister pack |
$1.61 |
$1.74 |
Setrona (Douglas) |
5% |
1 November 2022 |
1 April 2023 |
3. Tenders awarded to Pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand (Supplier) |
DV Limit |
Listing date |
Principal Supply Status date |
Brand |
|---|---|---|---|---|---|---|---|---|
|
Domperidone |
Tab 10 mg; 100 tablet blister pack |
$2.85 |
$4.00 |
Domperidone Viatris (Viatris) |
5% |
1 February 2023 |
1 July 2023 |
Pharmacy Health (API Consumer brands) |
|
Fluoxetine hydrochloride |
Cap 20 mg; 90 capsule blister pack |
$2.91 (per 84 capsules) |
$3.13 |
Arrow – Fluoxetine (Teva) |
5% |
1 January 2023 |
1 June 2023 |
Fluox |
|
Fluoxetine hydrochloride |
Tab dispersible 20 mg, scored; 28 tablet blister pack |
$1.84 |
$2.50 |
Fluox (pharmacode 2618575) (Viatris) |
5% |
1 September 2022 |
1 February 2023 |
Fluox (pharmacode 2077817) (Viatris) |
|
Ondansetron |
Inj 2 mg per ml, 2 ml ampoule; 5 ampoule pack |
$1.50 |
$1.42 |
Ondansetron-AFT (AFT) |
5% |
1 October 2022 |
1 March 2023 |
Ondansetron-Baxter (Baxter) |
|
Ondansetron |
Inj 2 mg per ml, 4 ml ampoule; 5 ampoule pack |
$2.20 |
$1.89 |
Ondansetron-AFT (AFT) |
5% |
1 October 2022 |
1 March 2023 |
Ondansetron Kabi (Fresenius Kabi) |
|
Pantoprazole |
Tab EC 20 mg; 90 tablet bottle |
$2.02 (per 100 tablets) |
$1.99 |
Panzop Relief (Viatris) |
5% |
1 February 2023 |
1 July 2023 |
Panzop Relief (pharmacode 2496216) (Viatris) |
|
Pantoprazole |
Tab EC 40 mg; 90 tablet bottle |
$2.85 (per 100 tablets) |
$2.74 |
Panzop Relief (Viatris) |
5% |
1 February 2023 |
1 July 2023 |
Panzop Relief (pharmacode 2496224) (Viatris) |
|
Piperacillin with tazobactam |
Inj 4 g with tazobactam 0.5 g vial; 1 vial pack |
$38.00 (per 10 vials) |
$3.59 |
PipTaz-AFT (AFT) |
5% |
1 September 2022 |
1 February 2023 |
PipTaz Sandoz (Sandoz) PiperTaz Sandoz (Sandoz) |
|
Posaconazole |
Tab modified-release 100 mg; 24 tablet blister pack |
$869.86 |
$206.00 |
Posaconazole Juno (Juno) |
5% |
1 November 2022 |
1 April 2023 |
Noxafil |
|
Water |
Inj 10 ml ampoule; 50 ampoule pack |
$7.19 |
$7.60 |
Multichem (Multichem) |
5% |
1 April 2023 |
1 September 2023 |
Pfizer |
Tender declines - Products where no tender is to be awarded for Principal Supply Status
Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the:
- 2020/21 Invitation to Tender, dated 2 November 2020
|
Chemical name |
Line item |
|---|---|
|
Fenofibrate |
Cap/tab 48 mg |
|
Fenofibrate |
Cap/tab 145 mg |
For products included in the 2019/20, 2020/21 or 2021/22 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.